These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17101054)

  • 1. Evaluation of herbal cannabis characteristics by medical users: a randomized trial.
    Ware MA; Ducruet T; Robinson AR
    Harm Reduct J; 2006 Nov; 3():32. PubMed ID: 17101054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology.
    Potter DJ; Clark P; Brown MB
    J Forensic Sci; 2008 Jan; 53(1):90-4. PubMed ID: 18279244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis use in Spanish patients with multiple sclerosis: fulfilment of patients' expectations?
    Martínez-Rodríguez JE; Munteis E; Carreño M; Blanco Y; Roquer J; Abanades S; Graus F; Saiz A
    J Neurol Sci; 2008 Oct; 273(1-2):103-7. PubMed ID: 18691726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
    Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
    Rog DJ; Nurmikko TJ; Young CA
    Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
    Russo EB; Guy GW; Robson PJ
    Chem Biodivers; 2007 Aug; 4(8):1729-43. PubMed ID: 17712817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of Australians using cannabis for medical purposes.
    Swift W; Gates P; Dillon P
    Harm Reduct J; 2005 Oct; 2():18. PubMed ID: 16202145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-efficacy, social support and service integration at medical cannabis facilities in the San Francisco Bay area of California.
    Reiman AE
    Health Soc Care Community; 2008 Jan; 16(1):31-41. PubMed ID: 18181813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
    J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.
    Abrams DI; Jay CA; Shade SB; Vizoso H; Reda H; Press S; Kelly ME; Rowbotham MC; Petersen KL
    Neurology; 2007 Feb; 68(7):515-21. PubMed ID: 17296917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Ghaffar O; Feinstein A
    Neurology; 2008 Jul; 71(3):164-9. PubMed ID: 18272863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis; adverse effects from an oromucosal spray.
    Scully C
    Br Dent J; 2007 Sep; 203(6):E12; discussion 336-7. PubMed ID: 17703180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.
    Jones AW; Holmgren A; Kugelberg FC
    Addiction; 2008 Mar; 103(3):452-61. PubMed ID: 18190663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responses to cannabis potency: a typology of users based on self-reported consumption behaviour.
    Korf DJ; Benschop A; Wouters M
    Int J Drug Policy; 2007 May; 18(3):168-76. PubMed ID: 17689363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
    Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study.
    Winstock AR; Lea T; Copeland J
    J Psychopharmacol; 2009 Jan; 23(1):84-93. PubMed ID: 18515451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.